Brief: Leads Biolabs And Dianthus Therapeutics Announce Initiation Of Phase 1 Trial Of LBL-047 (Dnth212) In Healthy Volunteers And Patients With Systemic Lupus Erythematosus

Dianthus Therapeutics

23/12/2025 11:02

Dec 23 (Reuters) - Nanjing Leads Biolabs 9887.HK:

LEADS BIOLABS AND DIANTHUS THERAPEUTICS ANNOUNCE INITIATION OF PHASE 1 TRIAL OF LBL-047 (DNTH212) IN HEALTHY VOLUNTEERS AND PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

NANJING LEADS BIOLABS CO LTD:  TOP-LINE RESULTS IN HEALTHY VOLUNTEERS ANTICIPATED IN 2H'26

Source text: ID:nGNX5742Sr

Further company coverage: 9887.HK

 ((Reuters.Briefs@thomsonreuters.com;))